NEW YORK (GenomeWeb News) – A patent infringement suit filed a year ago by Beckman Coulter and Orchid Cellmark against Sequenom has been dismissed, Sequenom disclosed in a filing with US Securities and Exchange Commission today.

Sequenom said that on June 22, the parties filed a stipulation of dismissal with the US District Court for the Southern District of California in which the claims made by Beckman and Orchid were dismissed, as were the counterclaims by Sequenom. The parties agreed to bear their own attorneys' fees and costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.